Press Releases Choose Year All Items 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 Search Press Releases Found 265 Results December 30, 2015 Relmada Therapeutics Announces Results of Annual Meeting of Stockholders December 28, 2015 Relmada Therapeutics Recommends Stockholders Vote “FOR” Relmada’s Director Nominees on the WHITE Proxy Card Today December 23, 2015 U.S. Federal Court Grants Preliminary Injunction Against Laidlaw & Company and its Principals Matthew Eitner and James Ahern December 21, 2015 Relmada Sends Letter To Stockholders Highlighting Significant Progress In Value Creation Strategy Overseen By Board And Management Team December 15, 2015 Leading Independent Proxy Advisory Firm Glass Lewis Recommends Relmada Stockholders Vote the WHITE Proxy Card “FOR” Relmada’s Director Nominees: Shreeram Agharkar and Maged Shenouda December 14, 2015 Pharmaceutical Industry Leader James Dolan Joins Relmada Therapeutics Advisory Team December 11, 2015 U.S. Federal Court Issues Temporary Restraining Order Against Laidlaw & Company and its Principals Matthew Eitner and James Ahern December 10, 2015 Relmada Therapeutics Announces Additional Information Regarding Positive Topline Results for Proof-of-Concept Study with BuTab December 9, 2015 Relmada Therapeutics Files Federal Lawsuit Against Laidlaw & Company and its Principals Matthew Eitner and James Ahern to Protect Interests of Relmada Stockholders December 9, 2015 Relmada Therapeutics Announces Positive Topline Results for Proof-of-Concept Study with BuTab «...192021222324...»
